NGeneBio Co., Ltd. (KOSDAQ:354200)
2,145.00
+65.00 (3.13%)
At close: Mar 12, 2026
24.06% (1Y)
| Market Cap | 56.02B +66.9% |
| Revenue (ttm) | 9.98B +61.7% |
| Net Income | -12.96B |
| EPS | -771.98 |
| Shares Out | 26.12M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 263,951 |
| Average Volume | 521,967 |
| Open | 2,115.00 |
| Previous Close | 2,080.00 |
| Day's Range | 2,055.00 - 2,190.00 |
| 52-Week Range | 1,325.00 - 2,765.00 |
| Beta | 1.31 |
| RSI | 55.42 |
| Earnings Date | Mar 20, 2026 |